Healthcare provider profile · identity verified

Brian Casey Fitzgerald, MD

Family Practice · GAINESVILLE, FL · NPI 1093158685

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	678	218
Amlodipine Besylate	Amlodipine Besylate	619	196
Lisinopril	Lisinopril	458	141
Gabapentin	Gabapentin	356	94
Omeprazole	Omeprazole	348	102
Levothyroxine Sodium	Levothyroxine Sodium	292	89
Losartan Potassium	Losartan Potassium	258	87
Metoprolol Succinate	Metoprolol Succinate	238	66
Albuterol Sulfate Hfa	Albuterol Sulfate	227	60
Metformin Hcl	Metformin Hcl	220	67
Rosuvastatin Calcium	Rosuvastatin Calcium	215	70
Pantoprazole Sodium	Pantoprazole Sodium	214	61
Fluticasone Propionate	Fluticasone Propionate	200	76
Tamsulosin Hcl	Tamsulosin Hcl	192	60
Pravastatin Sodium	Pravastatin Sodium	179	61
Hydrochlorothiazide	Hydrochlorothiazide	172	52
Metformin Hcl Er	Metformin Hcl	163	51
Eliquis	Apixaban	150	40
Duloxetine Hcl	Duloxetine Hcl	149	37
Carvedilol	Carvedilol	138	45
Trazodone Hcl	Trazodone Hcl	136	44
Jardiance	Empagliflozin	129	28
Tramadol Hcl	Tramadol Hcl	129	27
Sertraline Hcl	Sertraline Hcl	125	33
Alprazolam	Alprazolam	124	24
Metoprolol Tartrate	Metoprolol Tartrate	114	29
Ozempic	Semaglutide	114	24
Furosemide	Furosemide	112	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	101	38
Simvastatin	Simvastatin	85	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	23
Buspirone Hcl	Buspirone Hcl	80	24
Potassium Chloride	Potassium Chloride	80	30
Chlorthalidone	Chlorthalidone	79	26
Allopurinol	Allopurinol	78	23
Citalopram Hbr	Citalopram Hydrobromide	77	26
Ezetimibe	Ezetimibe	76	21
Diclofenac Sodium	Diclofenac Sodium	74	29
Escitalopram Oxalate	Escitalopram Oxalate	66	21
Montelukast Sodium	Montelukast Sodium	63	21
Famotidine	Famotidine	62	19
Ropinirole Hcl	Ropinirole Hcl	62	14
Spironolactone	Spironolactone	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	15
Glipizide Er	Glipizide	57	15
Prednisone	Prednisone	57	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	11
Meloxicam	Meloxicam	54	18
Clopidogrel	Clopidogrel Bisulfate	53	20
Warfarin Sodium	Warfarin Sodium	53	14
Ventolin Hfa	Albuterol Sulfate	52	14
Hydroxyzine Hcl	Hydroxyzine Hcl	49	16
Triamcinolone Acetonide	Triamcinolone Acetonide	49	21
Amitriptyline Hcl	Amitriptyline Hcl	48	11
Symbicort	Budesonide/Formoterol Fumarate	46	13
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Tizanidine Hcl	Tizanidine Hcl	45	13
Pregabalin	Pregabalin	43	suppressed
Xarelto	Rivaroxaban	41	suppressed
Ibuprofen	Ibuprofen	40	suppressed
Nifedipine Er	Nifedipine	40	suppressed
Bumetanide	Bumetanide	39	16
Entresto	Sacubitril/Valsartan	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Sildenafil Citrate	Sildenafil Citrate	36	suppressed
Spiriva Handihaler	Tiotropium Bromide	36	suppressed
Tresiba Flextouch U-100	Insulin Degludec	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	29
Atrovent Hfa	Ipratropium Bromide	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	11
Droplet Pen Needle	Pen Needle, Diabetic	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Baclofen	Baclofen	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Ketoconazole	Ketoconazole	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Topiramate	Topiramate	28	suppressed
Finasteride	Finasteride	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	12
Methocarbamol	Methocarbamol	26	suppressed
Atenolol	Atenolol	25	suppressed
Diazepam	Diazepam	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	20
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Azithromycin	Azithromycin	17	16
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Mirtazapine	Mirtazapine	17	suppressed
Temazepam	Temazepam	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Estradiol	Estradiol	15	suppressed
Indapamide	Indapamide	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Nystatin	Nystatin	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Chlorzoxazone	Chlorzoxazone	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error